Chicago Partners Investment Group LLC Iovance Biotherapeutics, Inc. Transaction History
Chicago Partners Investment Group LLC
- $3.63 Billion
- Q4 2025
A detailed history of Chicago Partners Investment Group LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Chicago Partners Investment Group LLC holds 40,589 shares of IOVA stock, worth $100,254. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40,589
Previous 40,580
0.02%
Holding current value
$100,254
Previous $88,000
13.64%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding IOVA
# of Institutions
291Shares Held
222MCall Options Held
2.41MPut Options Held
1.7M-
Mhr Fund Management LLC New York, NY29MShares$71.5 Million10.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA27.2MShares$67.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$52.4 Million0.0% of portfolio
-
State Street Corp Boston, MA13.3MShares$32.9 Million0.0% of portfolio
-
Invenomic Capital Management LP Boston, MA10.5MShares$26 Million1.15% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $390M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...